BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10084741)

  • 21. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease.
    Madero L; González-Vicent M; Molina J; Madero R; Quintero V; Díaz MA
    Bone Marrow Transplant; 2000 Aug; 26(4):365-9. PubMed ID: 10982281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis.
    Locatelli F; Perotti C; Torretta L; Maccario R; Montagna D; Ravelli A; Giorgiani G; De Benedetti F; Giraldi E; Magnani ML; De Stefano P; Martini A
    Haematologica; 1999 Sep; 84(9):839-43. PubMed ID: 10477459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Collection and transfusion of peripheral blood stem cells].
    Höcker P; Wagner A
    Beitr Infusionsther; 1991; 28():242-6. PubMed ID: 1725629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small children.
    Berger M; Kanold J; Rapatel C; deLumley L; Lutz P; Plantaz D; Vannier JP; Mechinaud F; Bergeron C; Favrot M; Gembara P; Halle-Hauss P; Bonhomme J; Travade P; Deméocq F
    Bone Marrow Transplant; 1997 Aug; 20(3):191-8. PubMed ID: 9257886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J; Moraleda JM; Ortuño F; Lozano ML; Ayala F; Vallejo C; de Arriba F; Vicente V
    Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell procurement and transplantation in paediatric patients.
    Höcker P; Emminger W; Peters C
    Transfus Sci; 1994 Dec; 15(4):339-42. PubMed ID: 10155551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
    Lefrère F; Hermine O; Audat F; Buzyn A; Cavazzana-Calvo M; Boccaccio C; Varet B
    Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.
    Balduzzi A; Perseghin P; Dassi M; Bonanomi S; Rovelli A; Gaipa G; Biondi A; Uderzo C
    Bone Marrow Transplant; 2002 Oct; 30(7):413-6. PubMed ID: 12368951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants.
    Figuerres E; Haut PR; Olzewski M; Kletzel M
    Bone Marrow Transplant; 2000 Mar; 25(6):583-8. PubMed ID: 10734291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
    Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and safety of peripheral blood stem cell collection in children with poor-prognosis solid tumors: a single center experience.
    Dolgopolov I; Yankelevich M; Andreeva L; Mscheidze D; Ijoguine D; Siegel S; Mentkevich G
    Pediatr Hematol Oncol; 1999; 16(4):291-8. PubMed ID: 10407865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy.
    Waller CF; von Lintig F; Daskalakis A; Musahl V; Lange W
    Bone Marrow Transplant; 1999 Jul; 24(1):19-24. PubMed ID: 10435729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Cui X; Shao Y; Ren B; Tong Z; Ren X; Li L; Zhang Z; Zhang N; Dai R; Hao X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):247-9. PubMed ID: 11876989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
    Venditti A; Battaglia A; Del Poeta G; Buccisano F; Maurillo L; Tamburini A; Del Moro B; Epiceno AM; Martiradonna M; Caravita T; Santinelli S; Adorno G; Picardi A; Zinno F; Lanti A; Bruno A; Suppo G; Franchi A; Franconi G; Amadori S
    Bone Marrow Transplant; 1999 Nov; 24(9):1019-27. PubMed ID: 10556963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The number of particular hematopoietic progenitors cells and the haematopoietic recovery following Allo PBSCT.
    Knopińska-Posłuszny W; Zaucha J; Bieniaszewska M; Hałaburda K; Hellmann A
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S92-5. PubMed ID: 9916648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
    Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
    Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.